Your browser doesn't support javascript.
loading
Temsirolimus versus Pazopanib (TemPa) in Patients with Advanced Clear-cell Renal Cell Carcinoma and Poor-risk Features: A Randomized Phase II Trial.
Tannir, Nizar M; Msaouel, Pavlos; Ross, Jeremy A; Devine, Catherine E; Chandramohan, Anuradha; Gonzalez, Graciela M Nogueras; Wang, Xuemei; Wang, Jennifer; Corn, Paul G; Lim, Zita D; Pruitt, Lisa; Karam, Jose A; Wood, Christopher G; Zurita, Amado J.
Afiliação
  • Tannir NM; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: ntannir@mdanderson.org.
  • Msaouel P; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ross JA; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Devine CE; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chandramohan A; Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Gonzalez GMN; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wang J; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Corn PG; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Lim ZD; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pruitt L; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Karam JA; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wood CG; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Zurita AJ; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Eur Urol Oncol ; 3(5): 687-694, 2020 10.
Article em En | MEDLINE | ID: mdl-31272939
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Carcinoma de Células Renais / Sirolimo / Indazóis / Neoplasias Renais Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Carcinoma de Células Renais / Sirolimo / Indazóis / Neoplasias Renais Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article